Nick Leschly, Director at bluebird bio, Inc. (BLUE), sold 4,290 shares at $7.80 ($33K) on 2023-01-11, disclosed to the SEC on 2023-01-13.
Seasonal sale ($33k) by Director — this insider has traded BLUE in January in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| TSVT | SELL | 2024-01-05 | $560K | — | Filing → |
| TSVT | SELL | 2023-08-24 | $102K | — | Filing → |
| TSVT | SELL | 2023-08-07 | $111K | — | Filing → |